Anna Schubart Selected Research

Enzymes

7/2015

Reduced Activity of Sphingosine-1-Phosphate Lyase Induces Podocyte-related Glomerular Proteinuria, Skin Irritation, and Platelet Activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Schubart Research Topics

Disease

7	Multiple Sclerosis 01/2021 - 02/2002
7	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 02/2002
4	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2023 - 12/2016
4	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 07/2003
3	Macular Degeneration (Age-Related Maculopathy) 01/2023 - 12/2016
3	Inflammation (Inflammations) 11/2019 - 12/2004
2	Infections 01/2023 - 01/2022
2	Atypical Hemolytic Uremic Syndrome 01/2023 - 11/2020
2	Encephalomyelitis (Myeloencephalitis) 11/2019 - 02/2002
1	Hidradenitis Suppurativa 01/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Skin Diseases (Skin Disease) 01/2023
1	Neoplasms (Cancer) 01/2021
1	Atrophy 01/2021
1	Arthritis (Polyarthritis) 01/2019
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2019
1	Hemolysis 01/2019
1	Pathologic Processes 01/2016
1	Gliosis 01/2016
1	Proteinuria 07/2015
1	Autoimmune Diseases (Autoimmune Disease) 07/2015
1	Chlamydia Infections 08/2003
1	Relapsing-Remitting Multiple Sclerosis 02/2002
1	Disease Progression 02/2002

Drug/Important Bio-Agent (IBA)

5	Complement System Proteins (Complement)IBA 01/2023 - 11/2020
5	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021 - 07/2003
3	AutoantibodiesIBA 01/2023 - 07/2003
3	AntibodiesIBA 01/2023 - 12/2004
3	siponimodIBA 11/2019 - 01/2016
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 07/2015 - 11/2008
2	Neuroprotective AgentsIBA 11/2019 - 01/2016
2	LyasesIBA 07/2015 - 06/2014
2	Proteins (Proteins, Gene)FDA Link 10/2003 - 08/2003
1	Immunoglobulin G (IgG)IBA 01/2023
1	LectinsIBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Lysine (L-Lysine)FDA Link 01/2023
1	tesidolumabIBA 01/2022
1	Complement Factor B (Factor B)IBA 01/2019
1	Complement Factor D (Factor D)IBA 12/2016
1	Peptide Hydrolases (Proteases)FDA Link 12/2016
1	Psychosine (Galactosylsphingosine)IBA 02/2016
1	CytokinesIBA 02/2016
1	Interleukin-6 (Interleukin 6)IBA 02/2016
1	LipidsIBA 02/2016
1	sphingosine 1-phosphate lyase (aldolase)IBA 07/2015
1	EnzymesIBA 07/2015
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2008
1	AntigensIBA 12/2004
1	AutoantigensIBA 10/2003
1	Immunoglobulin D (IgD)IBA 07/2003
1	EpitopesIBA 07/2003
1	Minocycline (Cyclops)FDA LinkGeneric 02/2002
1	Tetracycline (Achromycin)FDA LinkGeneric 02/2002

Therapy/Procedure

3	Therapeutics 02/2016 - 11/2008
1	Treatment Delay 01/2021
1	Oral Administration 01/2019